Quantitative immunofluorescence, anti-ras p21 antibody specificity, and cellular oncoprotein levels
- 1 March 1990
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 167 (2) , 464-470
- https://doi.org/10.1016/0006-291x(90)92046-3
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Luminescence Digital Imaging MicroscopyAnnual Review of Biophysics, 1989
- Ras oncogene expression as a prognostic indicator in rectal adenocarcinomaJournal of Surgical Research, 1988
- Reported binding of monoclonal antibody RAP-5 to formalin-fixed tissue sections is not indicative of ras p21 expressionHuman Pathology, 1988
- DNA cytometry and cytology by quantitative fluorescence image analysis in symptomatic bladder cancer patientsInternational Journal of Cancer, 1987
- ras GENESAnnual Review of Biochemistry, 1987
- Evaluation of a monoclonal antibody to ras peptide, RAP-5, claimed to bind preferentially to cells of infiltrating carcinomasBritish Journal of Cancer, 1986
- Expression ofrasOncogene p21 in Prostate CancerNew England Journal of Medicine, 1986
- ras Oncogene p21 expression is increased in premalignant lesions and high grade bladder carcinoma.The Journal of Experimental Medicine, 1985
- Monoclonal antibodies of predefined specificity detect activated ras gene expression in human mammary and colon carcinomas.Proceedings of the National Academy of Sciences, 1984
- Results of the automated analysis of 328 bladder specimens using the Leyden television analysis system (LEYTAS)World Journal of Urology, 1983